BRM.V

BioRem Inc.
TSXVCADEQUITY Industrials DELAYED
Last price
3.63
▼ 0.15 (3.97%)
MARKET ·

Price

Open
3.79
Prev close
3.78
Day high
3.81
Day low
3.59
Volume
33.33K
Market cap
$58.93M
P/E (TTM)
10.68
52W range
1.87 – 3.95

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
397.61K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jun 29, 26
Webb (Derek)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
EXERCISE 90.00K $21.87K Direct
Jun 26, 26
Biorem Inc
Issuer
BUY 10.70K $22.92K Direct
Jun 26, 26
Biorem Inc
Issuer
10.70K Direct
Jun 10, 26
Biorem Inc
Issuer
BUY 300 $654 Direct
Jun 10, 26
Biorem Inc
Issuer
300 Direct
Jun 8, 26
Biorem Inc
Issuer
BUY 900 $1.96K Direct
Jun 8, 26
Biorem Inc
Issuer
900 Direct
Jun 5, 26
Biorem Inc
Issuer
BUY 1.00K $2.18K Direct
Jun 5, 26
Biorem Inc
Issuer
1.00K Direct
Sep 19, 25
Biorem Inc
Issuer
BUY 20.00K $29.00K Direct
Sep 19, 25
Biorem Inc
Issuer
20.00K Direct
Sep 18, 25
Biorem Inc
Issuer
BUY 4.60K $6.67K Direct
Sep 18, 25
Biorem Inc
Issuer
4.60K Direct
Sep 12, 25
Webb (Derek)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
BUY 2.00K $3.06K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

2 reporting
NameRelationShares heldLatest
Biorem Inc
Issuer 10.70K Redemption, retraction, cancelation, repurchase
Webb (Derek)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) 412.37K Exercise of options

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 3.63
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.47% -3.1%
1M
+21.00% +17.3%
3M
+8.68% +5.6%
6M
+37.50% +26.4%
YTD
+34.44% +22.2%
1Y
+77.94% +57.9%
3Y
+286.17% +212.0%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$58.93M
Enterprise value$53.81M
Revenue (TTM)$50.70M
Gross profit$15.41M
EBITDA$8.60M
Net income$6.22M
EPS (TTM)$0.34
Free cash flow$-2.10M
Total cash$7.19M
Total debt$2.49M
Book value / share$1.09
Shares outstanding16.23M
Float15.71M
Short % of float
Dividend yield
Beta (5Y)0.85

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
2.82K
Prior 11.50K
Change vs prior
-75.5%
Shorts covering
% of float
% of shares out
0.03%
Against total outstanding
Days to cover
0.1
Liquid
Float
15.71M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Valuation & profitability ratios

Account required
Trailing P/E10.68
Forward P/E
PEG ratio
Price / sales
Price / book3.33
EV / revenue1.06
EV / EBITDA6.25
Gross margin30.40%
Operating margin17.17%
Profit margin12.26%
Return on equity43.57%
Return on assets16.58%
Debt / equity14.17
Current ratio2.04
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $42.36M$37.42M$25.17M$28.86M +13.2%
Operating revenue $42.36M$37.42M$25.17M$28.86M +13.2%
Cost of revenue $29.59M$27.36M$18.14M$20.10M +8.1%
Gross profit $12.77M$10.06M$7.02M$8.76M +27.0%
Research & development $48.16K$43.86K$30.44K$97.12K +9.8%
Selling, general & admin $6.14M$5.62M$3.91M$5.79M +9.4%
Total operating expense $6.19M$5.66M$3.94M$6.12M +9.4%
Operating income $6.57M$4.39M$3.09M$2.64M +49.6%
Net interest income -$161.98K-$195.48K-$273.44K-$257.18K +17.1%
Pre-tax income $6.33M$4.15M$2.79M$2.38M +52.6%
Tax provision $1.51M$1.10M$609.74K$770.35K +36.9%
Net income $4.82M$3.04M$2.18M$1.61M +58.2%
Net income to common $4.82M$3.04M$2.18M$1.61M +58.2%
Basic EPS 0.300.190.140.10 +57.9%
Diluted EPS 0.260.160.130.09 +62.5%
EBIT $6.49M$4.34M$3.06M$2.64M +49.4%
EBITDA $6.96M$4.82M$3.45M$2.99M +44.5%
Basic shares 16.03M15.76M15.67M15.48M +1.7%
Diluted shares 18.64M18.71M17.11M17.55M -0.4%

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 0.34 1 $52.10M
Next year 0.43 1 $58.90M +13.1%

Analyst targets & ownership

Account required
Mean target$4.50
High target$4.50
Low target$4.50
Implied upside23.97%
Analyst count1
ConsensusNONE
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders2.47%
Held by institutions0.15%
Institutions holding1
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
3.76
-3.41% from price
SMA 20
3.62
+0.25% from price
SMA 50
3.29
+10.37% from price
SMA 100
3.15
+15.06% from price
SMA 200
2.84
+27.93% from price
EMA 12
3.68
-1.24% from price
EMA 26
3.54
+2.51% from price
EMA 50
3.38
+7.32% from price
RSI (14)
54.5
Neutral
MACD (12,26,9)
0.13
Hist -0.02
ATR (14)
0.15
4.25% of price
Realised vol 30D
59.6%
Annualised
Bollinger upper
4.10
20, 2σ
Bollinger lower
3.14
20, 2σ
50 / 200 cross
Golden
3.29 vs 2.84
Trend bias
Above 200
+27.93%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.12
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
59.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-18.9%
Peak to trough
Max drawdown 5Y
-47.5%
Peak to trough
ATR 14
0.15
4.25% of price
Beta (reported)
0.85
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.